160 related articles for article (PubMed ID: 33772489)
1. Lung Cancer Screening: Evidence, Risks, and Opportunities for Implementation.
Tringali G; Milanese G; Ledda RE; Pastorino U; Sverzellati N; Silva M
Rofo; 2021 Oct; 193(10):1153-1161. PubMed ID: 33772489
[TBL] [Abstract][Full Text] [Related]
2. Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population Targeting.
Kaaks R; Delorme S
Rofo; 2021 May; 193(5):527-536. PubMed ID: 33212540
[TBL] [Abstract][Full Text] [Related]
3. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
5. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
6. Low-dose CT for lung cancer screening: opportunities and challenges.
Shen H
Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
[TBL] [Abstract][Full Text] [Related]
7. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
9. Lung Cancer Screening by Low-Dose Computed Tomography: Part 2 - Key Elements for Programmatic Implementation of Lung Cancer Screening.
Delorme S; Kaaks R
Rofo; 2021 Jun; 193(6):644-651. PubMed ID: 33212539
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
Silva M; Pastorino U; Sverzellati N
Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
[TBL] [Abstract][Full Text] [Related]
11. Update on Lung Cancer Screening.
Brownlee AR; Donington JS
Semin Respir Crit Care Med; 2020 Jun; 41(3):447-452. PubMed ID: 32450597
[TBL] [Abstract][Full Text] [Related]
12. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
[TBL] [Abstract][Full Text] [Related]
13. European position statement on lung cancer screening.
Oudkerk M; Devaraj A; Vliegenthart R; Henzler T; Prosch H; Heussel CP; Bastarrika G; Sverzellati N; Mascalchi M; Delorme S; Baldwin DR; Callister ME; Becker N; Heuvelmans MA; Rzyman W; Infante MV; Pastorino U; Pedersen JH; Paci E; Duffy SW; de Koning H; Field JK
Lancet Oncol; 2017 Dec; 18(12):e754-e766. PubMed ID: 29208441
[TBL] [Abstract][Full Text] [Related]
14. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
16. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
17. [Statement paper on the implementation of a national organized program in Germany for the early detection of lung cancer in risk populations using low-dose CT screening including management of screening findings].
Vogel-Claussen J; Blum TG; Andreas S; Bauer TT; Barkhausen J; Harth V; Kauczor HU; Pankow W; Welcker K; Kaaks R; Hoffmann H; ; ; ; ; ;
Rofo; 2024 Feb; 196(2):134-153. PubMed ID: 37816377
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
